TCRT Alaunos Therapeutics, Inc.

Fundamentals / CIK 0001107421 / USD

Alaunos Therapeutics, Inc. reported $3.0K in revenue and a net loss of $3.62M for the trailing twelve months ended September 30, 2026 (down 50.0% year over year), with a -121033.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TCRT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$33.13M$16.56M$0-$155.9MFY 2016 Revenue: $6.86MFY 2016 Net Income: -$165.3M2016FY 2017 Revenue: $15.90MFY 2017 Net Income: -$54.32M2017FY 2018 Revenue: $146KFY 2018 Net Income: -$53.12M2018FY 2019 Net Income: -$117.8M2019FY 2020 Revenue: $0FY 2020 Net Income: -$79.98M2020FY 2021 Revenue: $398KFY 2021 Net Income: -$78.75M2021FY 2022 Revenue: $2.92MFY 2022 Net Income: -$37.73M2022FY 2023 Revenue: $5.0KFY 2023 Net Income: -$4.68M2023FY 2024 Revenue: $10KFY 2024 Net Income: -$4.68M2024FY 2025 Revenue: $5.0KFY 2025 Net Income: -$4.18M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $5.0K $10K $5.0K $2.92M $398K $0 -- $146K $15.90M $6.86M
Research & Development $1.36M $362K $16.28M $25.02M $49.64M $52.70M $38.33M $34.13M $45.08M $157.8M
Total Operating Expenses $4.23M $4.82M $34.27M $38.03M $77.95M $80.36M $57.86M $54.05M $59.88M --
Operating Income -$4.22M -$4.81M -$34.27M -$35.10M -$77.55M -$80.36M -$57.86M -$53.91M -$53.49M -$165.3M
EBITDA -$4.22M -$4.81M -$31.95M -$32.35M -$74.95M -$79.23M -$57.23M -$53.33M -$53.12M -$165.0M
Interest Expense -- $0 $1.92M $3.15M $1.19M -- -- -- -- --
Income Tax Expense $0 -- -- -- -- -- -- -- -- --
Net Income -$4.18M -$4.68M -$4.68M -$37.73M -$78.75M -$79.98M -$117.8M -$53.12M -$54.32M -$165.3M
Basic EPS -$2.20 -$2.92 -$21.97 -$3,895.52 -$8,283.58 -$8,507.46 -$15,671.64 $21,492.54 -$11,865.67 -$29,552.24
Diluted EPS -$2.20 -$2.92 -$21.97 -$3,895.52 -$8,283.58 -$8,507.46 -$15,671.64 $21,492.54 -$11,865.67 -$29,552.24
Basic Shares Outstanding 1.9M 1.6M 1.6M 9.7K 9.6K 9.4K 7.5K 6.4K 6.1K 5.8K
Diluted Shares Outstanding 1.9M 1.6M 1.6M 9.7K 9.6K 9.4K 7.5K 6.4K 6.1K 5.8K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $3.0K $0 $0 $2.0K $4.0K
Research & Development $227K $388K $427K $361K $469K $185K $347K -$86K
Total Operating Expenses $760K $952K $1.01M $910K $1.19M $1.04M $1.09M $759K
Operating Income -$760K -$952K -$1.01M -$907K -$1.19M -$1.04M -$1.09M -$755K
EBITDA -$752K -$943K -$1.00M -$900K -$1.19M -$1.04M -$1.09M -$756K
Net Income -$772K -$952K -$1.01M -$893K -$1.16M -$1.05M -$1.07M -$742K
Basic EPS -$0.31 -$0.41 -$0.59 -- -$0.55 -$0.63 -$0.67 --
Diluted EPS -$0.31 -$0.41 -$0.59 -- -$0.55 -$0.63 -$0.67 --
Basic Shares Outstanding 2.6M 2.4M 1.9M -- 2.2M 1.7M 1.6M --
Diluted Shares Outstanding 2.6M 2.4M 1.9M -- 2.2M 1.7M 1.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $1.39M $1.09M $6.06M $39.06M $76.05M $115.1M $79.74M $61.73M $70.95M $81.05M
Cash & Short-Term Investments $1.39M $1.09M $6.06M $39.06M $76.05M $115.1M $79.74M $61.73M $70.95M $81.05M
Accounts Receivable, Net $3.0K $5.0K $1.0K $4.0K $1.11M $4.67M $3.33M $1.86M $19K $21K
Total Current Assets $1.99M $2.75M $8.26M $53.80M $78.83M $130.6M $105.5M $84.28M $90.78M $104.9M
Property, Plant & Equipment, Net $91K $0 $2.0K $8.46M $10.94M $10.23M $1.11M $1.10M $1.21M $843K
Other Non-Current Assets -- -- $0 $500K $631K $745K $110K $9.54M $13.48M $493K
Total Non-Current Assets $978K $0 $2.0K $11.14M $16.03M $15.76M $3.62M $10.77M $14.82M $1.46M
Total Assets $2.97M $2.75M $8.26M $64.94M $94.86M $146.3M $109.1M $95.05M $105.6M $106.3M
Accounts Payable $613K $516K $616K $1.39M $1.37M $960K $906K $707K $4.42M $156K
Short-Term Debt -- -- $0 $16.77M $7.87M $0 -- -- -- --
Deferred Revenue (Current) -- -- -- -- -- -- -- -- $6.39M $6.39M
Total Current Liabilities $813K $692K $1.96M $24.17M $16.04M $18.37M $12.53M $9.48M $20.86M $15.81M
Long-Term Debt -- $0 $0 $0 $16.25M $0 -- -- -- --
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- -- $35.14M $41.53M
Other Non-Current Liabilities -- -- $0 $28K $0 -- -- -- -- --
Total Non-Current Liabilities $0 $0 $0 $2.22M $20.77M $4.00M $1.58M $4.0K $37.56M $42.52M
Total Liabilities $813K $692K $1.96M $26.38M $36.81M $22.36M $14.10M $9.49M $58.42M $58.33M
Total Debt (incl. Leases) -- $0 $0 $22.26M $34.61M $9.63M $4.70M -- -- --
Common Stock $2.0K $2.0K $2.0K $16K $216K $215K $182K $161K $143K $132K
Retained Earnings -$924.6M -$920.4M -$915.8M -$880.6M -$842.9M -$764.1M -$684.1M -$566.3M -$712.4M -$658.0M
Total Stockholders' Equity $2.15M $2.06M $6.31M $38.55M $58.06M $124.0M $95.01M $85.56M -$96.81M -$77.30M
Total Equity $2.15M $2.06M $6.31M $38.55M $58.06M $124.0M $95.01M $85.56M -$96.81M -$77.30M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $615K $124K $354K $1.39M $1.94M $2.88M $319K $1.09M
Cash & Short-Term Investments $615K $124K $354K $1.39M $1.94M $2.88M $319K $1.09M
Accounts Receivable, Net $0 $0 $0 $3.0K $0 $2.0K $2.0K $5.0K
Total Current Assets $1.08M $666K $970K $1.99M $2.69M $3.74M $1.07M $2.75M
Property, Plant & Equipment, Net $66K $74K $82K $91K $97K -- -- $0
Total Non-Current Assets $842K $850K $913K $978K $1.04M $997K $1.05M $0
Total Assets $1.92M $1.52M $1.88M $2.97M $3.72M $4.74M $2.12M $2.75M
Accounts Payable $796K $732K $400K $613K $843K $809K $831K $516K
Total Current Liabilities $947K $864K $595K $813K $921K $1.07M $1.06M $692K
Long-Term Debt -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $947K $864K $595K $813K $921K $1.07M $1.06M $692K
Total Debt (incl. Leases) -- -- -- -- -- -- -- $0
Common Stock $3.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K
Retained Earnings -$927.4M -$926.6M -$925.6M -$924.6M -$923.7M -$922.6M -$921.5M -$920.4M
Total Stockholders' Equity $971K $652K $1.29M $2.15M $2.80M $3.66M $1.06M $2.06M
Total Equity $971K $652K $1.29M $2.15M $2.80M $3.66M $1.06M $2.06M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$4.18M -$4.68M -$4.68M -$37.73M -$78.75M -$79.98M -$117.8M -$53.12M -$54.32M -$165.3M
Depreciation & Amortization $7.0K $2.0K $2.31M $2.76M $2.60M $1.13M $629K $575K $369K $290K
Stock-Based Compensation $796K $435K $2.80M $3.53M $10.77M $6.83M $6.34M $7.53M $8.45M $8.45M
Change in Receivables $2.0K -$4.0K $3.0K $1.11M $3.56M -$1.33M -$1.47M -$1.84M $2.0K $425K
Change in Payables $97K -$100K -$773K -$25K $274K $54K $199K -$3.71M $4.26M -$1.85M
Operating Cash Flow -$2.87M -$4.97M -$30.14M -$29.23M -$61.47M -$57.01M -$40.85M -$49.46M -$54.67M -$58.33M
Capital Expenditure -$98K $0 -$197K -$216K -$3.32M -$9.78M -$284K -$459K -$737K -$551K
Free Cash Flow -$2.97M -$4.97M -$30.34M -$29.45M -$64.79M -$66.79M -$41.14M -$49.92M -$55.41M -$58.88M
Investing Cash Flow -$98K $0 $1.35M -$193K -$3.32M -$9.78M -$284K -$459K -$737K -$551K
Common Stock Issued -- $0 $92K $14.72M $0 -- -- -- $47.27M --
Share Repurchases -- -- $0 -$45K $0 -- -$653K -$1.62M $0 -$2.0K
Financing Cash Flow $3.26M $0 -$18.14M $6.37M $25.78M $102.1M $59.15M $40.31M $45.30M -$788K
Net Change in Cash $294K -$4.97M -$46.93M -$23.06M -$39.02M $35.33M $18.01M -$9.61M -$10.11M -$59.66M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$772K -$952K -$1.01M -$893K -$1.16M -$1.05M -$1.07M -$742K
Depreciation & Amortization $8.0K $9.0K $8.0K $7.0K $0 $0 $0 -$1.0K
Stock-Based Compensation $175K $246K $141K $243K $301K $184K $68K $81K
Change in Receivables $0 $0 $3.0K -$3.0K $2.0K $0 $3.0K -$5.0K
Change in Payables $65K $330K -$212K -$230K $34K -$22K $315K $59K
Operating Cash Flow -$425K -$300K -$1.03M -$552K -$844K -$701K -$772K -$592K
Capital Expenditure -- -- -- -- -- -- -- $0
Free Cash Flow -- -- -- -- -- -- -- -$592K
Investing Cash Flow -- -- -- -- -- -- -- $0
Common Stock Issued -- -- -- -- -- -- -- $0
Financing Cash Flow -- -- -- -- -- -- -- $0
Net Change in Cash $491K -$230K -$1.03M -$553K -$941K $2.56M -$772K -$592K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -84500.0% -48120.0% -685340.0% -1201.4% -19484.7% -- -- -36921.9% -336.4% -2409.4%
Net Profit Margin -83520.0% -46790.0% -93580.0% -1291.2% -19786.7% -- -- -36381.5% -341.7% -2409.2%
Return on Equity (ROE) -194.0% -226.8% -74.2% -97.9% -135.6% -64.5% -124.0% -62.1% -- --
Return on Assets (ROA) -140.8% -169.8% -56.6% -58.1% -83.0% -54.6% -108.0% -55.9% -51.4% -155.4%
Current Ratio 2.45x 3.98x 4.22x 2.23x 4.91x 7.11x 8.42x 8.89x 4.35x 6.63x
Quick Ratio 1.71x 1.58x 3.10x 1.62x 4.81x 6.52x 6.63x 6.71x 3.40x 5.13x
Debt to Equity -- 0.00x 0.00x 0.58x 0.60x 0.08x 0.05x -- -- --
Revenue Growth (YoY) -50.0% +100.0% -99.8% +634.2% -- -- -- -99.1% +131.7% --
EPS Growth (YoY) -- -- -- -- -- -- -172.9% -- -- --
5Y Revenue / Share Growth -- -- -100.0% -88.4% -96.5% -- -- -- +1039.8% +420.7%
10Y Revenue / Share Growth -- -- -- +32.1% -81.6% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -121033.3% -135266.7% -138166.7% -84500.0% -67883.3% -67266.7% -41630.0% -53477.8%
Net Profit Margin -120766.7% -133666.7% -136966.7% -83520.0% -67083.3% -66550.0% -40710.0% -52000.0%
Return on Equity (ROE) -373.1% -615.0% -319.0% -194.0% -143.6% -109.1% -384.8% -226.9%
Return on Assets (ROA) -188.9% -264.5% -218.2% -140.8% -108.1% -84.3% -192.0% -169.9%
Current Ratio 1.14x 0.77x 1.63x 2.45x 2.92x 3.48x 1.00x 3.98x
Quick Ratio 0.65x 0.14x 0.59x 1.71x 2.10x 2.68x 0.30x 1.58x
Debt to Equity -- -- -- -- -- -- -- 0.00x
Revenue Growth (YoY) -- -- -100.0% -25.0% -- -100.0% +100.0% +300.0%
Net Income Growth (YoY) -- -- -- -- -- -- -- -103.3%
Source: SEC EDGAR CompanyFacts (CIK 0001107421) · from December 31, 2003 Data through September 30, 2026 · synced Nov 21, 2026, 05:08 UTC · Open in terminal